Our care team of faculty, physician-scientists, neurologists, PhD scientists, nurses, and research coordinators. We seek to understand the mechanisms underlying ALS, muscular dystrophy (Duchenne Muscular Dystrophy, FSHD), and other neuromuscular diseases by investigating the biology, genes, proteins, and pathways known or suspected to contribute to neurodegeneration. We offer support services designed to increase the quality of life for our patients. Our specialists strive to manage your expectations and needs, including medication strategies and treatment options with clinical trial intervention.
Our clinical research investigations include both observational and interventional studies. Observational studies do not involve therapy or treatment but aim to gather information about the fundamental causes of neuromuscular diseases. Interventional studies involve investigational drugs and strive to gain an understanding of the safety of the drug and whether it can help slow or stop disease progression.
UMass Chan, Clinical Trials – Conquering Diseases and independent research studies
Professor: Academic Profile
UMass Memorial: Physician Profile
The Neuromuscular Medicine Clinic and Research Center at UMass Chan is committed to providing leading treatment care.
Our goal is to help advance new potential treatments through neuroscience and clinical trials. Check this page regularly, as we are building our clinical trials program and will be adding more applicable trials soon.
If you are interested in any of the clinical trials below, please email [catherine.douthwright@umassmed.edu]
Study name: Healey ALS Platform Clinical Trial
A perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Participants will have an equal chance to be randomized to all regimens that are active at the time of screening. Once randomized to a regimen, participants will be randomized in a 3:1 ratio to either study drug or placebo.
Active - Recruiting
